-
公开(公告)号:US20120238576A1
公开(公告)日:2012-09-20
申请号:US13376964
申请日:2010-06-07
申请人: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , Lukasz Koroniak , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , Lukasz Koroniak , Neil Desai
IPC分类号: A61K31/53 , C07D417/14 , A61K31/5377 , C07D403/14 , C07D403/12 , A61P35/00 , A61P9/10 , A61P25/00 , A61P9/04 , A61P19/02 , A61P37/00 , A61P27/02 , A61P29/00 , A61P37/06 , A61P17/02 , A61P7/10 , A61P11/00 , C07D413/14 , A61P9/00 , C07D417/12
CPC分类号: A61K31/53 , A61K45/06 , A61K2300/00
摘要: The present invention comprises inter alia compounds as shown in formula (I) or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明尤其包括式(I)所示的化合物或其药学上可接受的盐。
-
公开(公告)号:US20130023497A1
公开(公告)日:2013-01-24
申请号:US13376956
申请日:2010-06-07
申请人: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , Neil Desai
IPC分类号: C07D401/14 , C07D413/14 , C07D417/14 , C07D409/14 , C07D403/14 , C07D487/14 , C07D487/04 , A61K31/53 , A61K31/5377 , A61K31/655 , A61K31/635 , A61K31/538 , A61K31/541 , A61P35/00 , A61P43/00 , A61P9/00 , A61P19/02 , A61P9/10 , A61P37/00 , A61P27/02 , A61P37/06 , A61P29/00 , A61P17/02 , A61P11/00 , A61P31/00 , C07D401/12
CPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14
摘要: The present invention comprises inter alia triazine compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.
摘要翻译: 本发明尤其包括式(I)所示的三嗪化合物及其药学上可接受的盐。
-
公开(公告)号:US09078902B2
公开(公告)日:2015-07-14
申请号:US13376814
申请日:2010-06-09
申请人: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
IPC分类号: C07D403/14 , C07D405/14 , C07D409/14 , A61K31/496 , A61K31/53 , C07D403/12 , C07D417/12 , C07D417/14 , A61P35/00 , C07D401/14
CPC分类号: A61K31/53 , A61K31/496 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
摘要: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
摘要翻译: 本发明提供三嗪衍生物,并进一步提供使用这些化合物调节蛋白激酶和治疗由蛋白激酶介导的疾病和病症的方法。
-
4.BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS 有权
标题翻译: 苄基取代的TRIAZINE衍生物及其治疗应用公开(公告)号:US20120264759A1
公开(公告)日:2012-10-18
申请号:US13377031
申请日:2010-06-08
申请人: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
IPC分类号: A61K31/53 , A61P35/00 , A61P9/04 , A61P9/10 , A61P11/00 , A61P27/02 , A61P37/02 , A61P29/00 , A61P37/06 , C07D403/04 , A61P19/02
CPC分类号: C07D417/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12
摘要: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
摘要翻译: 本发明提供了三嗪化合物及其用于调节蛋白激酶和治疗由所述蛋白激酶介导的疾病的方法。
-
公开(公告)号:US20120196860A1
公开(公告)日:2012-08-02
申请号:US13376814
申请日:2010-06-09
申请人: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
IPC分类号: A61K31/5377 , C07D409/14 , A61K31/53 , C07D413/14 , C07D403/14 , C07D401/14 , A61P35/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P19/02 , A61P27/02 , A61P37/06 , A61P29/00 , A61P17/02 , A61P11/00 , C07D405/14
CPC分类号: A61K31/53 , A61K31/496 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
摘要: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
摘要翻译: 本发明提供三嗪衍生物,并进一步提供使用这些化合物调节蛋白激酶和治疗由蛋白激酶介导的疾病和病症的方法。
-
6.UREIDOPHENYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS 审中-公开
标题翻译: UREIDOPHENYL替代TRIAZINE衍生物及其治疗应用公开(公告)号:US20120202818A1
公开(公告)日:2012-08-09
申请号:US13376818
申请日:2010-06-09
申请人: Chunlin Tao , Qinwei Wang , Lukasz Koroniak , Laxman Nallan , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , Lukasz Koroniak , Laxman Nallan , Neil Desai
IPC分类号: A61K31/53 , C07D403/12 , C07D417/12 , A61P35/00 , A61P9/10 , A61P9/04 , A61P27/02 , A61P19/02 , A61P37/00 , A61P29/00 , A61P19/04 , A61P37/06 , A61P11/00 , A61P9/00 , C07D417/14
CPC分类号: A61K31/53 , C07D403/12 , C07D405/14 , C07D417/12 , C07D417/14
摘要: The present invention provides Uredophenyl substituted triazine derivatives and provides methods of using these compounds to modulate protein kinases and methods of using these compounds to treat protein kinase mediated diseases and conditions.
摘要翻译: 本发明提供Uredophenyl取代的三嗪衍生物,并提供使用这些化合物调节蛋白激酶的方法和使用这些化合物治疗蛋白激酶介导的疾病和病症的方法。
-
7.Benzyl substituted triazine derivatives and their therapeutical applications 有权
标题翻译: 苄基取代的三嗪衍生物及其治疗应用公开(公告)号:US08877924B2
公开(公告)日:2014-11-04
申请号:US13377031
申请日:2010-06-08
申请人: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
IPC分类号: C07D403/04 , C07D403/12 , C07D403/14 , C07D417/12 , C07D417/14 , C07D413/14 , C07D409/14 , C07D405/14
CPC分类号: C07D417/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12
摘要: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
摘要翻译: 本发明提供了三嗪化合物及其用于调节蛋白激酶和治疗由所述蛋白激酶介导的疾病的方法。
-
公开(公告)号:US20120172361A1
公开(公告)日:2012-07-05
申请号:US13376760
申请日:2010-06-07
申请人: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , David Ho , Neil Desai
发明人: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , David Ho , Neil Desai
IPC分类号: A61K31/53 , C07D403/12 , C07D251/38 , C07D413/14 , A61K31/5377 , A61P11/00 , A61P9/04 , A61P9/10 , A61P19/02 , A61P29/00 , A61P37/06 , A61P17/02 , C07D403/14 , A61P35/00
CPC分类号: C07D403/12 , C07D251/28 , C07D251/38 , C07D401/12 , C07D401/14 , C07D413/12 , C07D417/04 , C07D417/14
摘要: Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.
摘要翻译: 式(I)和式(II)的化合物及其药学上可接受的盐。
-
-
-
-
-
-
-